Clinical Trial

AZA Combined with R-GemOx for Elderly DLBCL Patients

Name: AZA Combined with R-GemOx for Elderly DLBCL Patients — clinical trial record (NCT06778902)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Dragon

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a prospective, single-arm, multicenter, phase II clinical trial to evaluate the efficacy and safety of AZA（azacytidine）combined with the R-GemOx (rituximab, gemcitabine and oxaliplatin) regimen as first-line treatment in elderly diffuse large B-cell lymphoma (DLBCL) patients.

Trial Details

NCT Number	NCT06778902
Lead Sponsor	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Conditions	DLBCL - Diffuse Large B Cell Lymphoma
Enrollment	80 participants
Start Date	2025-02-01
Primary Completion	2028-01-01 (estimated)
Study Completion	2028-01-01 (estimated)
Updated on ClinicalTrials.gov	2025-01-16